Glenn Buene
Norwegian University of Science and Technology(NO)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways, TGF-β signaling in diseases, Cytokine Signaling Pathways and Interactions, Parathyroid Disorders and Treatments
Most-Cited Works
- → Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss(2017)72 cited
- → Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells(2016)67 cited
- → BMPR2 inhibits activin and BMP signaling via wild-type ALK2(2018)58 cited
- → Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells(2016)47 cited
- → Monoclonal immunoglobulins promote bone loss in multiple myeloma(2020)30 cited
- → The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma(2015)28 cited
- → MYCamplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy(2015)25 cited
- → Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells(2021)20 cited
- → Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes(2018)16 cited
- → Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients(2014)13 cited